Captario simulates the future of Big Pharma
The innovative start-up company Captario has raised 50 million SEK to meet an increasing interest from the global pharma industry. Captario’s software makes it possible to analyze complex decisions in drug development in ways unheard of until now.
Investment AB Spiltan is the largest institutional investor when the Sahlgrenska Science Park company Captario gears up with an additional 50 million
